Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin ii receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: Implications for age-related macular degeneration

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2665-2681

  Pons, Marianne ^a   Cousins, Scott W ^b   Alcazar, Oscar ^a   Striker, Gary E ^c   Marin Castaño, Maria E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CD147 ANTIGEN; GELATINASE A; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; VISUAL PIGMENT;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETINA MACULA AGE RELATED DEGENERATION;

EID: 79959482055     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.006     Document Type: Article

References (85)

1. Fine SL, Berger JW, Maguire MG, Ho AC: Age-related macular degeneration. N Engl J Med 2000, 342:483-492 (Pubitemid 30100237)
2. Green WR: Histopathology of age-related macular degeneration. Mol Vis 1999, 5:27
3. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL III: Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report No. 19. Ophthalmology 2005, 112:533-539 (Pubitemid 41108849)
4. Evans JR: Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001, 20:227-253 (Pubitemid 32149928)
5. McConnell V, Silvestri G: Age-related macular degeneration. Ulster Med J 2005, 74:82-92 (Pubitemid 41448291)
6. Hayreh SS, Servais GE, Virdi PS :Macular lesions in malignant arterial hypertension. Ophthalmologica 1989, 198:230-246 (Pubitemid 19143851)
7. Hyman L, Schachat AP, He Q, Leske MC; Age-Related Macular Degeneration Risk Factors Study Group: Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol 2000, 118:351-358
8. Jonas JB, Hayreh SS, Martus P: Influence of arterial hypertension and diet-induced atherosclerosis on macular drusen. Graefes Arch Clin Exp Ophthalmol 2003, 241:125-134 (Pubitemid 36747800)
9. Klein R, Klein BE, Tomany SC, Cruickshanks KJ: The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003, 110: 636-643 (Pubitemid 36520056)
10. Lee MA, Bohm M, Paul M, Ganten D: Tissue renin-angiotensin systems: their role in cardiovascular disease. Circulation 1993, 87: IV7-IV13 (Pubitemid 23135644)
11. Taylor WR: Hypertensive vascular disease and inflammation: mechanical and humoral mechanisms. Curr Hypertens Rep 1999, 1:96-101
12. Berka JL, Stubbs AJ, Wang DZ, DiNicolantonio R, Alcorn D, Campbell DJ, Skinner SL: Renin-containing Muller cells of the retina display endocrine features. Invest Ophthalmol Vis Sci 1995, 36:1450-1458
13. Kohler K, Wheeler-Schilling T, Jurklies B, Guenther E, Zrenner: Angiotensin II in the rabbit retina. Vis Neurosci 1997, 14:63-71
14. Wagner J, Jan Danser AH, Derkx FH, de Jong TV, Paul M, Mullins JJ, Schalekamp MA, Ganten D: Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 1996, 80:159-163 (Pubitemid 26058551)
15. Wheeler-Schilling TH, Kohler K, Sautter M, Guenther E: Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat. Eur J Neurosci 1999, 11:3387-3394 (Pubitemid 29484235)
16. Savaskan E, Loffler KU, Meier F, Muller-Spahn F, Flammer J, Meyer P: Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Res 2004, 36:312-320 (Pubitemid 40069656)
17. Senanayake P, Drazba J, Shadrach K, Milsted A, Rungger-Brandle E, Nishiyama K, Miura S, Karnik S, Sears JE, Hollyfield JG: Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci 2007, 48:3301-3311 (Pubitemid 351261177)
18. Striker GE, Praddaude F, Alcazar O, Cousins SW, Marin-Castano ME: Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II. Am J Physiol Cell Physiol 2008, 295:C1633-C1646
19. Burns RP, Feeney-Burns L: Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc 1980, 78: 206-225 (Pubitemid 11035013)
20. Ishibashi T, Patterson R, Ohnishi Y, Inomata H, Ryan SJ: Formation of drusen in the human eye, Am J Ophthalmol 1986, 15:101:342-353
21. Zhu ZR, Goodnight R, Nishimura T, Sorgente N, Ogden TE, Ryan SJ: Experimental changes resembling the pathology of drusen in Bruch's membrane in the rabbit. Curr Eye Res 1998, 7:581-592
22. Atkison SJ, Petterson ML, Butler MJ, Murphy G: Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type I collagen in a cell model. FEBS Lett 2001, 491:222-226 (Pubitemid 32193800)
23. Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A: Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 1989, 58:3743-3750
24. Zhuge Y, Xu J: Rac1 mediates type I collagen-dependent MMP-2 activation: role in cell invasion across collagen barrier. J Biol Chem 2001, 276:16248-16256
25. Ebihara I, Nakamura T, Tomino Y, Koide H: Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Nephrol Dial Transplant 1997, 12: 1001-1006 (Pubitemid 27216326)
26. Praddaude F, Cousins SW, Pecher C, Marin-Castano ME: Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium. Exp Eye Res 2009, 89:109-118
27. Crabos M, Roth M, Hahn AW, Erne P: Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts: coupling to signaling systems and gene expression. J Clin Invest 1994, 93:2372-2378 (Pubitemid 24177148)
28. Iwami K, Ashizawa N, Do YS, Graf K, Hsueh WA: Comparison of ANG II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts. Am J Physiol 1996, 270:H2100-H2107
29. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T: Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 1991, 9:17-22
30. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000, 52:11-34 (Pubitemid 30127593)
31. Guo H, Zucker S, Gordon MK, Toole BP, Biswas C: Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 1997, 272:24-27 (Pubitemid 27021117)
32. Kanekura T, Chen X, Kanzaki T: Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002, 99:520-528 (Pubitemid 34461604)
33. Kataoka H, DeCastro R, Zucker S, Biswas C: Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 1993, 53:3154-3158 (Pubitemid 23210328)
34. Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T, Koono M, Wakisaka S: Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane- type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000, 157: 177-184 (Pubitemid 30629029)
35. Alcazar O, Hawkridge AM, Collier TS, Cousins SW, Bhattacharya SK, Muddiman DC, Marin-Castano ME: Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells. Mol Cell Proteomics 2009, 8:2201-2211
36. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono G, Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997, 275:90-94 (Pubitemid 27020316)
37. Sugden PH, Clerk A: Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 1997, 9:337-351 (Pubitemid 27367575)
38. Taniyama Y, Ushio-Fukai M, Hitomi H, Rocic P, Kingsley MJ, Pfahnl C, Weber DS, Alexander RW, Griendling KK: Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am J Physiol Cell Physiol 2004, 287:C494-C499 (Pubitemid 38955241)
39. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH: MAP kinases. Chem Rev 2001, 101:2449-2476 (Pubitemid 35373029)
40. Lewis TS, Shapiro PS, Ahn NG: Signal transduction through MAP kinase cascades. Adv Cancer Res 1998, 74:49-139 (Pubitemid 28193546)
41. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001, 22:153-183 (Pubitemid 32458157)
42. Makino N, Sugano M, Otsuka S, Hata T: Molecular mechanism of angiotensin II type 1 and type 2 receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension 1997, 30:796-802 (Pubitemid 27441104)
43. Gigante B, Piras O, de Paolis P, Porcellini A, Natale A, Volpe M: Role of angiotensin II AT2-subtype receptors in the blood pressure- lowering effect of losartan in salt-restricted rats. J Hypertens 1998, 16:2039-2043 (Pubitemid 29002385)
44. Thai H, Wollmuth J, Goldman S, Gaballa M: Angiotensin subtype 1 receptor (TA1) blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor. J Pharmacol Exp Ther 2003, 370:1171-1178 (Pubitemid 37494239)
45. Banes-Berceli AK, Ketsawatsomkron P, Ogbi S, Patel B, Pollock CM, Marrero GA: Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation. Am J Physiol Heart Circ Physiol 2007, 293:H1291-H1299 (Pubitemid 47254232)
46. Cousins SW, Marin-Castaño ME, Espinosa-Heidmann DG, Alexandridou A, Striker L, Elliot S: Female gender, estrogen loss, and sub-RPE deposit formation in aged mice. Invest Ophthalmol Vis Sci 2003, 44:50-59
47. Marin-Castaño ME, Elliot SJ, Potier M, Karl M, Striker LJ, Striker GE, Csaky KG, Cousins SW: Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003, 44:50-59 (Pubitemid 36138775)
48. Wang M, Takagi G, Asai K, Resuello RG, Natividad FF, Vatner DE, Vatner SF, Lakatta EG: Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 2002, 41:1308-1316 (Pubitemid 36706082)
49. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI: Mechanism of cell surface activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995, 270:5331-5338
50. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M: Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 2002, 20:4782-4793 (Pubitemid 32848631)
51. Abdelsalam A, Del Priore L, Zarbin MA: Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression (review). Surv Ophthalmol 1999, 44:1-29 (Pubitemid 29378350)
52. Nagai N, Oike Y, Izumi-Nagai K, Urano T, Kubota Y, Noda K, Ozawa Y, Inoue M, Tsubota K, Suda T, Ishida S: Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arterioscler Thromb Vasc Biol 2006, 26:2252-2259 (Pubitemid 44465719)
53. Lambert V, Wielockx B, Munaut C, Galopin C, Jost M, Itoh T, Werb Z, Baker A, Libert C, Krell HW, Foidart JM, Noel A, Rakic JM: MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 2003, 17:2290-2292 (Pubitemid 39561469)
54. Plantner JJ, Jiang C, Smine A: Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 1998, 67:637-645 (Pubitemid 29052401)
55. Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, Zierath JR: Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle: involvement of the mitogen- and stress-activated protein kinase 1. J Biol Chem 2000, 275:1457-1462 (Pubitemid 30051206)
56. Eguchi S, Matsumoto T, Motley ED, Utsunomiya H, Inagami T: Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells: possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 1986, 271:14169-14175
57. Fischer TA, Singh K, O'Hara DS, Kaye DM, Kelly RA: Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes. Am J Physiol 1998, 275(3 Pt 2):H906-H916
58. Terada Y, Tomita K, Homma MK, Nonoguchi H, Yang T, Yamada T, Yuasa Y, Krebs EG, Marumo F: Sequential activation of MAP kinase cascade by angiotensin II in opossum kidney cells. Kidney Int 1995, 48:1801-1809
59. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook NJ: Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 1996, 97:508-514 (Pubitemid 26039417)
60. Pellieux C, Sauthier T, Aubert JF, Brunner HR, Pedrazzini T: Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice. J Hypertens 2000, 18:1307-1317
61. Kudoh S, Komuro I, Mizuno T, Yamazaki T, Zou Y, Shiojima I, Takekoshi N, Yazaki Y: Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ Res 1997, 80:139-146 (Pubitemid 27030378)
62. Force T, Bonventre JV: Growth factors and mitogen-activated protein kinases. Hypertension 1998, 31:152-161
63. Zou Y, Komuro I, Yamazaki T, Kudoh S, Aikawa R, Zhu W, Shiojima I, Hiroi Y, Tobe K, Kadowaki T, Yazaki Y: Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts (review). Circ Res 1998, 82:337-345 (Pubitemid 28101191)
64. Schmitz U, Ishida T, Ishida M, Surapisitchat J, Hasham MI, Pelech S, Berk BC: Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK. Circ Res 1998, 82: 1272-1278 (Pubitemid 28294746)
65. Zohn IE, Yu H, Li X, Cox AD, Earp HS: Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase. Mol Cell Biol 1995, 15:6160-6168
66. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ: Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993, 268:24539-24542 (Pubitemid 23335456)
67. Murphy TJ, Alexander RV, Griendling KK, Runge MS, Bernstein KE: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991, 351:233-236 (Pubitemid 21896571)
68. D'Amore A, Black MJ, Thomas WG: The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 2005, 46:1347-1354 (Pubitemid 43189734)
69. Landon EJ, Inagami T: Beyond the G protein: the saga of the type 2 angiotensin II receptor. Arterioscler Thromb Vasc Biol 2005, 25:15-16 (Pubitemid 40054248)
70. Mehta PK, Griendling KK: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007, 292:C82-C97 (Pubitemid 46127306)
71. Lambert V, Wielockx B, Munaut C, Galopin C, Jost M, Itoh T, Werb Z, Baker A, Libert C, Krell HW, Foidart JM, Noel A, Rakic JM: MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 2003, 17:2290-2292 (Pubitemid 39561469)
72. Plantner JJ, Jiang C, Smine A: Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 1998, 67:637-645 (Pubitemid 29052401)
73. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI: Mechanism of cell surface activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995, 270:5331-5338
74. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M: Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 2002, 20:4782-4793 (Pubitemid 32848631)
75. Caudroy S, Polette M, Tournier JM, Burlet H, Toole B, Zucker S, Birembaut P: Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. J Histochem Cytochem 1999, 47: 1575-1580
76. Jimenez E, Perez de la Blanca E, Urso L, Gonzalez I, Salas J, Montiel M: Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells. Biochem Biophys Res Commun 2009, 380: 769-774
77. Saygili E, Rana OR, Meyer C, Gemein C, Andrzejewski MG, Ludwig A, Weber C, Schotten U, Kruttgen A, Weis J, Schwinger RH, Mischke K, Rassaf T, Kelm M, Schauerte P: The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases- 2/-9 in atrial myocytes. Basic Res Cardiol 2009, 104:435- 438, [Epub ahead of press January 15, 2009]
78. Chen XF, Wang JA, Hou J, Gui C, Tang LJ, Chen QX, Xie XJ, Jiang J, Cai FJ, Chen HS, Lu HS, Chen H: Extracellular matrix metalloproteinase inducer (EMMPRIN) is present in smooth muscle cells of human aneurysmal aorta and is induced by angiotensin II in vitro. Clin Sci (Lond) 2009, 116:819-826
79. Chen G, Hitomi M, Han J, Stacey DW: The p38 pathway provides negative feedback for Ras proliferative signaling. J Biol Chem 2000, 275:38973-38980 (Pubitemid 32058908)
80. Wang Z, Yang H, Tachado SD, Capo-Aponte JE, Bildin VN, Koziel H, Reinach PS: Phosphatase-mediated crosstalk control of ErK and p38 MAPK signaling in corneal epithelial cells. Invest Ophthalmol Vis Sci 2006, 47:5267-5275 (Pubitemid 46723774)
81. Kogkopoulou O, Tzakos E, Mavrothalassitis G, Baldari CT, Paliogianni F, Young HA, Thyphronitis G: Conditional up-regulation of IL-2 production by p38 MAPK inactivation is mediated by increased Erk1/2 activity. J Leukoc Biol 2006, 79:1052-1060 (Pubitemid 44835592)
82. Liu Q, Hofmann PA: Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ErK in apoptosis of cardiac myocytes. Am J Physiol Heart Circ Physiol 2004, 286:H2204-H2212 (Pubitemid 38685234)
83. Pons M, Cousins SW, Csaky KG, Striker G, Marin-Castaño ME: Cigarette smoke-related hydroquinone induces filamentous actin reorganization and heat shock protein 27 phosphorylation through p38 and extracellular signal-regulated kinase 1/2 in retinal pigment epithelium: implications for age-related macular degeneration. Am J Pathol 2010, 177:1198-1213
84. Keyse SM: Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 2000, 12:186-192 (Pubitemid 30142565)
85. Zhang H, Shi X, Hampong M, Blanis L, Pelech S: Stress-induced inhibition of ErK1 and ErK2 by direct interaction with p38 MAP kinase. J Biol Chem 2001, 276:6905-6908